Pancreatic resections in patients who refuse blood transfusions. The application of a perioperative protocol for a true bloodless surgery

Mario De Bellis,Domenico Girelli,Andrea Ruzzenente,Fabio Bagante,Raffaele Ziello,Tommaso Campagnaro,Simone Conci,Filippo Nifosì,Alfredo Guglielmi,Calogero Iacono
DOI: https://doi.org/10.1016/j.pan.2020.08.020
IF: 3.977
2020-10-01
Pancreatology
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>The refusal of blood transfusions compels surgeons to face ethical and clinical issues. A single-institution experience with a dedicated perioperative blood management protocol was reviewed to assess feasibility and short-term outcomes of true bloodless pancreatic surgery.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>The institutional database was reviewed to identify patients who refused transfusion and were scheduled for elective pancreatic surgery from 2010 through 2018. A protocol to optimize the hemoglobin values by administration of drugs stimulating erythropoiesis was systematically used.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Perioperative outcomes of 32 Jehovah's Witnesses patients were included. Median age was 67 years (range, 31–77). Nineteen (59.4%) patients were treated with preoperative erythropoietin. Twenty-four (75%) patients underwent pylorus-preserving pancreaticoduodenectomy, 4 (12.5%) distal pancreatectomy (DP) with splenectomy, 3 (9.4%) spleen-preserving DP, and 1 (3.1%) total pancreatectomy. Median estimated blood loss and surgical duration were 400 mL (range, 100–1000) and 470 min (range, 290–595), respectively. Median preoperative hemoglobin was 13.9 g/dL (range, 11.7–15.8) while median postoperative nadir hemoglobin was 10.5 g/dL (range, 7.1–14.1). The most common histological diagnosis (n = 15, 46.9%) was pancreatic ductal adenocarcinoma. Clavien-Dindo grade I-II complications occurred in fourteen (43.8%) patients while one (3.1%) patient had a Clavien-Dindo grade IIIa complication wich was an abdominal collection that required percutaneous drainage. <u>Six (18.8%) patients presented biochemical leak or postoperative pancreatic fistula grade B.</u> Median <u>hospital stay</u> was 16 days (range, 8–54) with no patient requiring transfusion or re-operation and no 90-day mortality.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>A multidisciplinary approach and specific perioperative management allowed performing pancreatic resections in patients who refused transfusion with good short-term outcomes.</p>
gastroenterology & hepatology
What problem does this paper attempt to address?